These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33854494)

  • 1. Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation.
    Sanchez-Infantes D; Stephens JM
    Front Immunol; 2020; 11():612013. PubMed ID: 33854494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
    Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
    J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
    Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
    J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.
    Sanchez-Infantes D; White UA; Elks CM; Morrison RF; Gimble JM; Considine RV; Ferrante AW; Ravussin E; Stephens JM
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E217-25. PubMed ID: 24297795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.
    Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
    J Biol Chem; 2014 May; 289(20):13821-37. PubMed ID: 24695736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Deficiency of TRAF5 Promotes Adipose Tissue Inflammation and Aggravates Diet-Induced Obesity in Mice.
    Gissler MC; Anto-Michel N; Pennig J; Scherrer P; Li X; Marchini T; Pfeiffer K; Härdtner C; Abogunloko T; Mwinyella T; Sol Mitre L; Spiga L; Koentges C; Smolka C; von Elverfeldt D; Hoppe N; Stachon P; Dufner B; Heidt T; Piepenburg S; Hilgendorf I; Bjune JI; Dankel SN; Mellgren G; Seifert G; Eisenhardt SU; Bugger H; von Zur Muhlen C; Bode C; Zirlik A; Wolf D; Willecke F
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2563-2574. PubMed ID: 34348490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance.
    Wang J; Badeanlou L; Bielawski J; Ciaraldi TP; Samad F
    Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E756-68. PubMed ID: 24473437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin M Induces Lipolysis and Suppresses Insulin Response in 3T3-L1 Adipocytes.
    Bailey JL; Hang H; Boudreau A; Elks CM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target.
    Komori T; Morikawa Y
    Anat Sci Int; 2018 Mar; 93(2):169-176. PubMed ID: 29103176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity.
    Piquer-Garcia I; Campderros L; Taxerås SD; Gavaldà-Navarro A; Pardo R; Vila M; Pellitero S; Martínez E; Tarascó J; Moreno P; Villarroya J; Cereijo R; González L; Reyes M; Rodriguez-Fernández S; Vives-Pi M; Lerin C; Elks CM; Stephens JM; Puig-Domingo M; Villarroya F; Villena JA; Sánchez-Infantes D
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e337-48. PubMed ID: 31606738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocyte Ceramides-The Nexus of Inflammation and Metabolic Disease.
    Chaurasia B; Talbot CL; Summers SA
    Front Immunol; 2020; 11():576347. PubMed ID: 33072120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose-tissue Treg cells restrain differentiation of stromal adipocyte precursors to promote insulin sensitivity and metabolic homeostasis.
    Wang G; Muñoz-Rojas AR; Spallanzani RG; Franklin RA; Benoist C; Mathis D
    Immunity; 2024 Jun; 57(6):1345-1359.e5. PubMed ID: 38692280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.
    Nishimoto S; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Murata C; Kim-Kaneyama JR; Sato F; Bando M; Yagi S; Soeki T; Hayashi T; Imoto I; Sakaue H; Shimabukuro M; Sata M
    Sci Adv; 2016 Mar; 2(3):e1501332. PubMed ID: 27051864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.
    Komori T; Tanaka M; Furuta H; Akamizu T; Miyajima A; Morikawa Y
    Diabetologia; 2015 Aug; 58(8):1868-76. PubMed ID: 25972231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid precursor protein expression is upregulated in adipocytes in obesity.
    Lee YH; Tharp WG; Maple RL; Nair S; Permana PA; Pratley RE
    Obesity (Silver Spring); 2008 Jul; 16(7):1493-500. PubMed ID: 18483477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling.
    van Krieken PP; Odermatt TS; Borsigova M; Blüher M; Wueest S; Konrad D
    Mol Metab; 2021 Dec; 54():101341. PubMed ID: 34547509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
    Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of infiltrating immune cells in dysfunctional adipose tissue.
    Guzik TJ; Skiba DS; Touyz RM; Harrison DG
    Cardiovasc Res; 2017 Jul; 113(9):1009-1023. PubMed ID: 28838042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide controls adipose tissue inflammation associated with high-fat diet-induced obesity in mice.
    Nakamitsu PZ; Compri CM; de Fraia Pinto L; Gotardo ÉM; de Oliveira CC; Ribeiro ML; Pedrazzoli J; Gambero A
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):151-8. PubMed ID: 25441253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.